- Coordinator
- Universidad Pompeu Fabra, Spain
- Runs
- 1 November 2026 to 30 April 2028
- Status
- Running
- EU funding
- €150k
- Total cost
- —
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101335427
What the project is doing
In the project's own words, from its summary on CORDIS.
SimOSpine addresses the clinical challenge of revision rates in spinal fusion surgery, primarily caused by Proximal Junctional Disease (PJD) and Adjacent-Level Disease (ALD). In long thoracolumbar fusions (LTLF), PJD-related revision rates exceed 20% within 2 years. In short lumbar fusions (SLF), ALD complications peak at 3–5 years, with revision rates reaching 8%, while 14%–18% of procedures are identified as unnecessary.
These failures are fundamentally mechanical, driven by altered lever arms adjacent to rigid instrumentation. Clinicians currently lack quantitative ""co-pilots"" to assess these risks pre-operatively. SimOSpine aims to transition a validated research technology (TRL 4) into a functional beta (TRL 5) Software as a Medical Device (SaMD) for real-time, patient-specific predictive prognosis. Exploiting breakthrough research from the ERC-funded O-Health project, it leverages Physics-Informed AI and Finite Element (FE) metamodeling to quantify failure risks.
Unlike competitors, it delivers precision biomechanical descriptors at clinical timescales without high-radiation CT scans. The project achieves its goals through four pillars:Real-Time Biomechanical Analysis: AI surrogates trained on extensive FE simulation atlases calculate risk indexes in seconds. X-ray-to-3D Reconstruction: Advanced transformer architectures generate high-fidelity 3D models from 2D biplanar X-rays, ensuring clinical accessibility and reduced radiation.
Mechanobiological Integration: For SLF, the system integrates Parallel Network biology to predict long-term tissue turnover, acknowledging the mechanobiological nature of ALD.Clinical Validation & Regulatory Compliance: Expanded validation with leading hospitals and implementation of ISO 13485/14971 frameworks aim for Class IIa MDR certification. SimOSpine will drive the creation of a university spin-off offering a privacy-compliant SaMD for surgeons to optimize fusion strategies, reducing complications and unnecessary surgeries.""
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universidad Pompeu Fabra | Barcelona | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI